Intellia Therapeutics

NTLA • NASDAQ • Stock Fundamentals

Intellia Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Leonard, with a market cap of $1.7B.

Market Cap$1.7B

Employees598.0

CEOJohn Leonard

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Intellia Therapeutics

Intellia Therapeutics (NTLA) has a market capitalization of $1.7B and trades on NASDAQ.

Intellia Therapeutics has approximately 598 employees.